Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.97 USD | +0.02% | 0.00% | +240.87% |
Financials (USD)
Sales 2024 * | 17.7M | Sales 2025 * | 20.23M | Capitalization | 4.46B |
---|---|---|---|---|---|
Net income 2024 * | -97M | Net income 2025 * | -114M | EV / Sales 2024 * | 231 x |
Net cash position 2024 * | 376M | Net cash position 2025 * | 302M | EV / Sales 2025 * | 205 x |
P/E ratio 2024 * |
-49.2
x | P/E ratio 2025 * |
-37.7
x | Employees | 142 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.02% | ||
Current month | +0.59% | ||
1 month | +0.64% | ||
3 months | +86.05% | ||
6 months | +331.12% | ||
Current year | +240.87% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +10.17% | - |
1st Jan change | Capi. | |
---|---|---|
+240.87% | 4.46B | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.43% | 21.83B | |
-10.63% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- ALPN Stock